Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Last trade$16.77
Day change-$0.27 (-1.58%)
Day range$16.58 – $17.48
Volume1,947,030
Market cap$4.18B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$4.18B
Price / earnings
144.25×
Price / book
2.34×
Price / sales
3.87×
EV / sales
4.61×
EV / EBITDA
22.86×
Profitability
Earnings per share
$0.12
Return on assets
0.83%
Return on equity
1.62%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.67×
Current ratio
3.02×
Quick ratio
2.49×
Cash ratio
1.36×
Cash flow
Price / cash flow
19.96×
Price / free cash flow
24.9×
Free cash flow
$168M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for MIR, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$277.8M
$266.8M
$257.6M
$277.4M
$223.1M
$222.9M
$202M
$254.3M
Cost of revenue
$146.3M
$133.7M
$138.5M
$141.9M
$118.6M
$120.4M
$105.9M
$132M
Gross profit
$131.5M
$133.1M
$119.1M
$135.5M
$104.5M
$102.5M
$96.1M
$122.3M
Selling, general and administrative
$104M
$105.1M
$105.8M
$99.9M
$87M
$82.6M
$78.7M
$85.2M
Research and development
$10.3M
$10.1M
$9.6M
$10.1M
$10.1M
$10M
$8.7M
$8.1M
Total operating expenses
$114.3M
$115.2M
$115.4M
$110M
$97.1M
$92.6M
$87.4M
$93.3M
Operating income
$17.2M
$17.9M
$3.7M
$25.5M
$7.4M
$9.9M
$8.7M
$29M
Interest expense
-$8.4M
-$8.4M
-$8.4M
-$9M
-$8.9M
-$11.8M
-$12.5M
-$13.2M
Income before taxes
$10.9M
$11.3M
-$5.2M
$23.1M
$1.2M
$7.8M
$600K
$15.7M
Income taxes
$3.1M
$3.2M
-$1.8M
$5.3M
-$1.9M
-$700K
$200K
-$200K
Net income
$7.8M
$8.1M
-$3.4M
$17.8M
$3.1M
$8.5M
$400K
$15.9M
Net income attributable to common shareholders
$7.4M
$7.7M
-$3.4M
$17.3M
$2.9M
$8.3M
$300K
$15M
EBITDA
$55.4M
$56.7M
$44.5M
$61.1M
$42.3M
$43.7M
$42.4M
$63.6M
Basic earnings per share
$0.03
$0.03
-$0.01
$0.07
$0.01
$0.04
$0.00
$0.07
Diluted earnings per share
$0.03
$0.03
-$0.01
$0.05
$0.01
$0.03
$0.00
$0.07
Recent news
Company coverage with links to the original publishers.
Mirion Technologies reported Q3 2026 revenue of $277.8 million, up 24.5% year-over-year, slightly missing the consensus estimate of $277.91 million. EPS matched expectations at $0.12. The Nuclear & Safety segment slightly beat estimates while Medical segment underperformed. Adjusted EBITDA in Nuclear & Safety fell short of analyst expectations at $49.8 million versus $54.38 million estimated.
Mirion Technologies reported Q3 2026 earnings of $0.12 per share, matching consensus estimates, with revenues of $277.8 million slightly missing expectations. The stock has declined 36.3% year-to-date versus the S&P 500's 12.1% gain. Assigned a Zacks Rank #3 (Hold), the company is expected to perform in line with the market going forward.
Aurora Innovation (AUR) is expected to report a year-over-year earnings decline despite higher revenues when it releases Q3 2026 results on October 28. The company is projected to post a quarterly loss of $0.12 per share (down 9.1% YoY) with revenues of $3.23 million (up 223% YoY). Consensus EPS estimates have been revised 2.86% lower over the last 30 days, indicating analyst caution about the company's near-term earnings prospects.
Mirion Technologies (MIR) closed at $16.22 with a mean analyst price target of $24, suggesting 48% upside potential. The stock has a Zacks Rank #2 (Buy) rating and shows positive earnings estimate revisions over the last 30 days. However, the article cautions that price targets alone should not be the sole basis for investment decisions, as analysts often set overly optimistic targets due to business incentives.
Mirion Technologies has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting rising earnings estimates over the past three months. The upgrade positions the company in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation driven by improving business fundamentals and institutional investor interest.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.